Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

The development of new strategic antimicrobial therapeutic approaches, such as drug repurposing, has become an urgent need. Previously, we reported that tamoxifen presents therapeutic efficacy against multidrug-resistant (MDR) <i>Acinetobacter baumannii</i>, <i>Pseudomonas aerugino...

Full description

Bibliographic Details
Main Authors: Andrea Miró-Canturri, Rafael Ayerbe-Algaba, Andrea Vila-Domínguez, Manuel E. Jiménez-Mejías, Jerónimo Pachón, Younes Smani
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Antibiotics
Subjects:
tamoxifen
tamoxifen metabolite
bacteria
infection
treatment
Online Access:https://www.mdpi.com/2079-6382/10/3/336

Similar Items

Similar Items